[Close]
- This page was created by volunteers like you!
- Help us make it even better. To learn more about contributing to MEpedia, click here.
- Join the movement
- Visit #MEAction to find support or take action. Donate today to help us improve and expand this project.
- Congratulations!
- MEpedia has got over 30 million views as of August 2022!
Baricitinib
From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
Baricitinib is a JAK (Janus Kinase) inhibitor and immunomodulatory drug currently FDA approved for Rheumatoid Arthritis, Alopecia Areata, and acute COVID-19. It is slated for a series of clinical trials for Long COVID run by Wes Ely funded by the NIH. [1]
- ↑ Fairbank, Rachel (April 2, 2024). "Long COVID still has no cure — so these patients are turning to research". Nature. 628 (8006): 26–28. doi:10.1038/d41586-024-00901-3.
